Mitsubishi UFJ Trust & Banking Corp lowered its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 92.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,585 shares of the company's stock after selling 137,200 shares during the period. Mitsubishi UFJ Trust & Banking Corp's holdings in Nutrien were worth $707,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the business. Vanguard Group Inc. grew its stake in Nutrien by 2.2% during the fourth quarter. Vanguard Group Inc. now owns 22,463,277 shares of the company's stock worth $1,386,546,000 after purchasing an additional 479,834 shares during the period. Arrowstreet Capital Limited Partnership grew its stake in Nutrien by 19.1% during the third quarter. Arrowstreet Capital Limited Partnership now owns 14,221,381 shares of the company's stock worth $834,962,000 after purchasing an additional 2,276,651 shares during the period. TD Asset Management Inc grew its stake in Nutrien by 16.5% during the third quarter. TD Asset Management Inc now owns 7,368,861 shares of the company's stock worth $432,838,000 after purchasing an additional 1,043,766 shares during the period. Capital International Investors grew its stake in Nutrien by 1.7% during the third quarter. Capital International Investors now owns 5,539,645 shares of the company's stock worth $325,325,000 after purchasing an additional 95,274 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in Nutrien by 1.5% during the third quarter. Dimensional Fund Advisors LP now owns 5,509,107 shares of the company's stock worth $323,409,000 after purchasing an additional 78,842 shares during the period. Institutional investors and hedge funds own 63.10% of the company's stock.
Nutrien Stock Up 1.9%
NTR stock opened at $77.30 on Wednesday. Nutrien Ltd. has a twelve month low of $53.03 and a twelve month high of $85.36. The company has a quick ratio of 0.70, a current ratio of 1.34 and a debt-to-equity ratio of 0.37. The stock's 50 day moving average is $74.97 and its 200-day moving average is $66.76. The firm has a market capitalization of $37.16 billion, a PE ratio of 16.59 and a beta of 0.64.
Nutrien (NYSE:NTR - Get Free Report) last posted its earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share for the quarter, missing analysts' consensus estimates of $0.87 by ($0.04). Nutrien had a net margin of 8.43% and a return on equity of 8.41%. The company had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same quarter in the prior year, the business earned $0.31 EPS. The firm's revenue for the quarter was up 5.1% compared to the same quarter last year. Sell-side analysts expect that Nutrien Ltd. will post 5.12 EPS for the current fiscal year.
Nutrien Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st were issued a $0.55 dividend. This is a boost from Nutrien's previous quarterly dividend of $0.55. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date was Tuesday, March 31st. Nutrien's dividend payout ratio is 47.21%.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on NTR shares. Canadian Imperial Bank of Commerce decreased their target price on Nutrien from $90.00 to $88.00 and set an "outperformer" rating for the company in a research note on Thursday, April 30th. UBS Group cut Nutrien from a "neutral" rating to a "sell" rating and raised their price objective for the company from $63.00 to $67.00 in a research note on Thursday, March 26th. BNP Paribas Exane cut Nutrien from an "outperform" rating to a "neutral" rating in a research note on Monday, February 23rd. Mizuho raised their price objective on Nutrien from $65.00 to $68.00 and gave the company a "neutral" rating in a research note on Friday, January 16th. Finally, BMO Capital Markets raised their price objective on Nutrien from $85.00 to $90.00 and gave the company an "outperform" rating in a research note on Wednesday, March 18th. Twelve analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $80.94.
Get Our Latest Analysis on NTR
About Nutrien
(
Free Report)
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
Read More
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.